{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:59:37Z","timestamp":1670331577064},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.rec.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T22:47:27Z","timestamp":1478818047000},"page":"1204-1213","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk"],"prefix":"10.1016","volume":"69","author":[{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Triant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2016.10.005_bib0210","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.recesp.2016.05.037","article-title":"HIV and Heart Disease: What Cardiologists Should Know","volume":"69","author":"Boccara","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2016.10.005_bib0215","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective study of acute HIV-1 infection in adults in East Africa and Thailand","volume":"374","author":"Robb","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0220","unstructured":"\u00c1rea de Vigilancia de VIH y Comportamientos de Riesgo. Vigilancia Epidemiol\u00f3gica del VIH y SIDA en Espa\u00f1a: Sistema de Informaci\u00f3n sobre Nuevos Diagn\u00f3sticos de VIH y Registro Nacional de Casos de Sida. Plan Nacional sobre el Sida - S.G. de Promoci\u00f3n de la Salud y Epidemiolog\u00eda\/Centro Nacional de Epidemiolog\u00eda - ISCIII. Madrid; Nov 2015 [accessed 2016 Sept 9]. Available at: http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/vigilancia\/InformeVIH_SIDA_2015.pdf."},{"key":"10.1016\/j.rec.2016.10.005_bib0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2016.10.005_bib0235","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/eht528","article-title":"HIV infection and cardiovascular disease","volume":"35","author":"Hemkens","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2016.10.005_bib0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: time for a better understanding","volume":"61","author":"Boccara","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2016.10.005_bib0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.108.790857","article-title":"Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIVDrugs (D:A:D Study)","volume":"119","author":"Worm","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0250","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"AIDS."},{"issue":"Suppl 1","key":"10.1016\/j.rec.2016.10.005_bib0255","first-page":"S1","article-title":"Epidemiology of coronary heart disease in patients with human immunodeficiency virus","volume":"15","author":"Triant","year":"2014","journal-title":"Rev Cardiovasc Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0260","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e32835a9950","article-title":"Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers","volume":"26","author":"Pereyra","year":"2012","journal-title":"AIDS."},{"issue":"Suppl 3","key":"10.1016\/j.rec.2016.10.005_bib0265","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1093\/infdis\/jis195","article-title":"HIV infection and coronary heart disease: an intersection of epidemics","volume":"205","author":"Triant","year":"2012","journal-title":"J Infect Dis."},{"key":"10.1016\/j.rec.2016.10.005_bib0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11904-013-0168-6","article-title":"Cardiovascular disease and HIV infection","volume":"10","author":"Triant","year":"2013","journal-title":"Curr HIV\/AIDS Rep."},{"key":"10.1016\/j.rec.2016.10.005_bib0275","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12012-010-9087-6","article-title":"Effects of the HIV-1 protein Tat on myocardial function and response to endotoxin","volume":"10","author":"McDonough","year":"2010","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.rec.2016.10.005_bib0280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.rec.2016.10.005_bib0285","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0300-8932(04)77230-9","article-title":"Recurrent coronary thrombosis, factor V Leiden, primary antiphospholipid syndrome and HIV","volume":"57","author":"Santos","year":"2004","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2016.10.005_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/cid\/cir829","article-title":"Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease","volume":"54","author":"Triant","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.rec.2016.10.005_bib0295","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"Currier","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0300","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCULATIONAHA.107.189625","article-title":"Effects of HIV infection and antiretroviral therapy on the heart and vasculature","volume":"118","author":"Dub\u00e9","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0305","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0310","unstructured":"European AIDS Clinical Society. Guidelines version 8.0. October 2015 [accessed 2016 Sept 5]. Available at: http:\/\/www.eacsociety.org\/files\/guidelines_8.0-english-revised_20160610.pdf."},{"key":"10.1016\/j.rec.2016.10.005_bib0315","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamainternmed.2014.4010","article-title":"Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals","volume":"175","author":"Okulicz","year":"2015","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0325","unstructured":"The HIV pharmacovigilance. Risk assessment tool system [accessed 2016 Sept 5]. Available at: http:\/\/www.chip.dk\/Tools."},{"key":"10.1016\/j.rec.2016.10.005_bib0330","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/CIRCULATIONAHA.107.189627","article-title":"Development of appropriate coronary heart disease risk prediction models in HIV-infected patients","volume":"118","author":"Schambelan","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.107.189622","article-title":"State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS: executive summary","volume":"118","author":"Grinspoon","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0340","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1161\/CIRCULATIONAHA.107.189628","article-title":"Prevention strategies for cardiovascular disease in HIV-infected patients","volume":"118","author":"Stein","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0345","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/CIRCULATIONAHA.107.189623","article-title":"Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors","volume":"118","author":"Grunfeld","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0350","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu076","article-title":"Aspirin use for primary and secondary prevention in human immunodeficiency virus (HIV)-Infected and HIV-uninfected patients","volume":"1","author":"Suchindran","year":"2014","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.rec.2016.10.005_bib0355","doi-asserted-by":"crossref","first-page":"e0153103","DOI":"10.1371\/journal.pone.0153103","article-title":"Determinants of smoking and quitting in HIV-Infected Individuals","volume":"11","author":"Regan","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.rec.2016.10.005_bib0360","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","article-title":"Pathophysiology and management of cardiovascular disease in patients with HIV","volume":"4","author":"Nou","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.rec.2016.10.005_bib0365","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2015.5498","article-title":"Exploring statins to decrease HIB-related heart disease risk","volume":"314","author":"Mitka","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2016.10.005_bib0370","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ajh\/hpt182","article-title":"Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study","volume":"27","author":"De Socio","year":"2014","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.rec.2016.10.005_bib0375","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamainternmed.2013.264","article-title":"Getting to the heart of HIV and myocardial infarction","volume":"173","author":"Mallon","year":"2013","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.rec.2016.10.005_bib0380","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration","volume":"371","author":"Sabin","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2016.10.005_bib0385","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Lancet HIV."},{"key":"10.1016\/j.rec.2016.10.005_bib0390","first-page":"1","article-title":"Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012","volume":"20","author":"Quiros-Roldan","year":"2016","journal-title":"AIDS Care."},{"key":"10.1016\/j.rec.2016.10.005_bib0395","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/jac\/dku190","article-title":"Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS)","volume":"69","author":"Palella","year":"2014","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.rec.2016.10.005_bib0400","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/infdis\/jiw082","article-title":"History of AIDS in HIV-infected patients is associated with higher in-hospital mortality following admission for acute myocardial infarction and stroke","volume":"213","author":"Okeke","year":"2016","journal-title":"J Infect Dis."},{"key":"10.1016\/j.rec.2016.10.005_bib0405","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","article-title":"Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database","volume":"127","author":"Lorgis","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.10.005_bib0410","unstructured":"HIV Drug Interactions. HIV Drug interaction checker [accessed 2016 Sept 5]. Available at: http:\/\/www.hiv-druginteractions.org."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716303255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716303255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T20:56:09Z","timestamp":1536267369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585716303255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1885585716303255"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2016.10.005","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}